- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.02. | Catheter Precision to sell atherectomy catheter assets, focus on electrophysiology | 1 | MassDevice | ||
| 19.02. | Catheter Precision Divests Non-Core Assets As It Shifts Focus | 1 | Benzinga.com | ||
| 19.02. | Catheter Precision, Inc.: Catheter Precision Announces Strategic Sale of Non-Core Assets to Strengthen Balance Sheet and Accelerate Electrophysiology Growth | 765 | GlobeNewswire (Europe) | FORT MILL, S.C., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a leader in advanced electrophysiology solutions, today announced it has entered into a definitive... ► Artikel lesen | |
| CATHETER PRECISION Aktie jetzt für 0€ handeln | |||||
| 17.02. | Catheter Precision acquires 20% stake in Creatd's aviation subsidiary | 1 | Investing.com | ||
| 17.02. | Catheter Precision steigt mit 20 % bei Luftfahrt-Tochter von Creatd ein | 2 | Investing.com Deutsch | ||
| 17.02. | CREATD INC.: VTAK Acquires 20% Interest in Creatd's Subsidiary Fly Flyte, Inc. | 65 | GlobeNewswire (Europe) | Strategic Partnership: Creatd expanded Fly Flyte's investor network by adding NYSE-listed VTAK as an investor in its subsidiary.Portfolio Expansion: Creatd continues advancing its portfolio strategy... ► Artikel lesen | |
| 17.02. | Catheter Precision, Inc.: VTAK Acquires 19.98% Strategic Stake in AI-Enabled Aviation Company Fly Flyte, Inc. | 192 | GlobeNewswire (Europe) | Immediate Exposure to Revenue-Generating, Asset-Backed Regional Air Mobility Business Positioned Ahead of Anticipated Future Industry-wide eVTOL Commercialization Strategic Investment Expands Capital... ► Artikel lesen | |
| 12.02. | Catheter Precision, Inc. Secures up to $36.5 Million in Strategic Institutional Financing to Accelerate Growth | 1 | GlobeNewswire (USA) | ||
| 06.02. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.01. | Catheter Precision, Inc.: Catheter Precision Receives First Purchase Order for LockeT in Germany | 776 | GlobeNewswire (Europe) | FORT MILL, S.C., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
| 20.01. | Catheter Precision, Inc.: Catheter Precision Received new VIVO Purchase Order from Leading Hospital in Slovenia | 4 | GlobeNewswire (USA) | ||
| 25.11.25 | Catheter Precision, Inc.: Historic Win for Electrophysiology Reimbursement in Ambulatory Surgery Centers Provides Unique Opportunity for Catheter Precision's LockeT Device | 979 | GlobeNewswire (Europe) | FORT MILL, S.C., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
| 21.11.25 | Catheter Precision, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.11.25 | Catheter Precision, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.11.25 | Catheter Precision reports Q3 results | 1 | Seeking Alpha | ||
| 13.11.25 | Catheter Precision, Inc.: Catheter Precision (VTAK) Reports Third Quarter and First Nine Months 2025 Results of Operations | 726 | GlobeNewswire (Europe) | FORT MILL, S.C., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on the cardiac electrophysiology marketplace... ► Artikel lesen | |
| 13.11.25 | Catheter Precision, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 16.10.25 | Catheter Precision, Inc.: Catheter Precision Enters Distribution Agreement with FuMedica AG to Bring LockeT to Switzerland | 239 | GlobeNewswire (Europe) | FORT MILL, S.C., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company and a leading developer of innovative solutions for cardiac procedures... ► Artikel lesen | |
| 15.10.25 | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.09.25 | Catheter Precision, Inc. Announces Two New Patents to be Issued by USPTO | 205 | GlobeNewswire (Europe) | FORT MILL, S.C., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen |
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 49,890 | -2,79 % | Fresenius: Weiteres Wachstum in Sicht - Aktie bärenstark | Am kommenden Mittwoch (25. Februar) wird der Gesundheitskonzern Fresenius die Zahlen für das vergangene vierte Quartal respektive Gesamtjahr 2025 vorlegen. Der Markt rechnet sowohl umsatz- als auch... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,020 | -0,51 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ECKERT & ZIEGLER | 14,870 | -1,98 % | EQS-AFR: Eckert & Ziegler SE: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Eckert & Ziegler SE
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Eckert & Ziegler SE: Vorabbekanntmachung... ► Artikel lesen | |
| BICO GROUP | 1,656 | -2,76 % | BICO Group AB: Publication of BICO Group AB: Year-end report 2025 | Strong Lab Automation growth and higher cash balance
Q4 2025 SummaryLab Automation delivered 15 percent organic sales growth YoY. This was primarily driven by accelerated project completions and additional... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,088 | +2,92 % | Sernova Biotherapeutics: Sernova Biotherapeutics Announces Warrant Amendments | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - February 20, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH0) ("the Company"), a leading regenerative medicine company... ► Artikel lesen | |
| CARDINAL HEALTH | 192,05 | -0,98 % | Cardinal Health report highlights cost savings and provider confidence in biosimilars | New analysis shows biosimilars are projected to strengthen cost savings and provider confidence across the healthcare ecosystem, with oncology leading in adoption... ► Artikel lesen | |
| RESMED | 216,00 | -0,37 % | ResMed At $250: Missed Opportunity Or A Trap In The Making? | ||
| ATOSSA THERAPEUTICS | 0,001 | -100,00 % | XFRA 7300,B0Y,YAG: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILZEROSTACK CORP.... ► Artikel lesen | |
| ZIMMER BIOMET | 80,74 | -3,05 % | Zimmer Biomet Holdings, Inc.: Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026 | WARSAW, Ind., Feb. 23, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board... ► Artikel lesen | |
| UNIDOC HEALTH | 0,071 | +7,56 % | UniDoc stellt Installation des H3 Health Cube in Italien fertig | - Der KI-gestützte Health Cube steht
ab sofort den Patienten im Dorf Guardia Perticara in der italienischen Region Basilikata zur Verfügung.
VANCOUVER, British Columbia... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results | Revenue increased 22% for the quarter ended December 31, 2025 and 33% for the nine months ended December 31, 2025 compared to prior yearNet loss and net loss per share decreased from prior year for... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,172 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.01.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 22.01.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.01.2026ISIN NameCA74290F1009 PROBE... ► Artikel lesen | |
| CYTOSORBENTS | 0,619 | -2,83 % | Cytosorbents Corp: CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update | Fourth quarter and Full-Year 2025 revenue are expected to be approximately $9.2 million and $37.0 million, respectively, with expected Q4 gross margins in the range... ► Artikel lesen | |
| VERU | 2,560 | -4,48 % | Veru Inc.: Veru Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress | -- Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track to initiate this quarter- --Company to host conference call and webcast... ► Artikel lesen | |
| CLARIANE | 3,870 | -4,49 % | Clariane: Full-year 2025 results | Solid 2025 resultsDebt reduction trajectory confirmedGrowth objectives for 2025-2028 All tables are available in the PDF. Successful plan to strengthen the financial position and confirmed debt... ► Artikel lesen |
CATHETER PRECISION INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 1,630 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CATHETER PRECISION INC finden Sie auf Wallstreet Online.